Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;18(4):277-88.
doi: 10.15430/jcp.2013.18.4.277.

Recent advances in in vivo genotoxicity testing: prediction of carcinogenic potential using comet and micronucleus assay in animal models

Affiliations
Review

Recent advances in in vivo genotoxicity testing: prediction of carcinogenic potential using comet and micronucleus assay in animal models

Seung Hun Kang et al. J Cancer Prev. 2013 Dec.

Abstract

Genotoxic events have been known as crucial step in the initiation of cancer. To assess the risk of cancer, genotoxicity assays, including comet, micronucleus (MN), chromosomal aberration, bacterial reverse, and sister chromatid exchange assay, can be performed. Compared with in vitro genotoxicity assay, in vivo genotoxicity assay has been used to verify in vitro assay result and definitely provide biological significance for certain organs or cell types. The comet assay can detect DNA strand breaks as markers of genotoxicity. Methods of the in vivo comet assay have been established by Japanese Center for the Validation of Alternative Methods (JaCVAM) validation studies depending on tissue and sample types. The MN can be initiated by segregation error and lagging acentric chromosome fragment. Methods of the in vivo MN assay have been established by Organization for Economic Co-operation and Development (OECD) test guidelines and many studies. Combining the in vivo comet and MN assay has been regarded as useful methodology for evaluating genetic damage, and it has been used in the assessment of potential carcinogenicity by complementarily presenting two distinct endpoints of the in vivo genotoxicity individual test. Few studies have investigated the quantitative relation between in vivo genotoxicity results and carcinogenicity. Extensive studies emphasizes that positive correlation is detectable. This review summarizes the results of the in vivo comet and MN assays that have investigated the genotoxicity of carcinogens as classified by the International Agency for Research on Cancer (IARC) carcinogenicity database. As a result, these genotoxicity data may provide meaningful information for the assessment of potential carcinogenicity and for implementation in the prevention of cancer.

Keywords: Carcinogenicity; Comet assay; In vivo genotoxicity; Micronucleus assay.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Conceptual scheme representing in vivo micronucleus and comet assay for carcinogenicity study.
Fig. 2.
Fig. 2.
Scheme illustrating alkaline version of in vivo comet assay.
Fig. 3.
Fig. 3.
Scheme showing main procedure of in vivo micronucleus assay.

Similar articles

Cited by

References

    1. Pratheepa Sivasankari N, Kaur S, Reddy KS, Vivekanandam S. Micronucleus Index: an early diagnosis in oral carcinoma. J Anat Soc India. 2008;57:8–13.
    1. Keen-Kim D, Nooraie F, Rao PN. Cytogenetic biomarkers for human cancer. Front Biosci. 2008;13:5928. - PubMed
    1. Miyamae Y, Yamamoto M, Sasaki YF, Kobayashi H, Igarashi-Soga M, Shimoi K, et al. Evaluation of a tissue homogenization technique that isolates nuclei for the in vivo single cell gel electrophoresis (comet) assay: a collaborative study by five laboratories. Mutat Res. 1998;418:131–40. - PubMed
    1. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458:719–24. - PMC - PubMed
    1. Brendler-Schwaab S, Hartmann A, Pfuhler S, Speit G. The in vivo comet assay: use and status in genotoxicity testing. Mutagenesis. 2005;20:245–54. - PubMed

LinkOut - more resources